News

Clinical Trials, webinar, CIMTEC,

CIMTEC is developing a series of free webinars for members of the medical imaging and digital pathology communities across Canada who are...

CIMTEC in the Globe and Mail, November 29, 2014

CIMTEC's Chief Scientific Officer and Centre Director, Dr. Aaron Fenster, is quoted in the Globe and Mail about the effectiveness of new...

CIMTEC article in Hill Times_Nov2014

The Hill Times Health Policy Briefing By Bart Sullivan CEO, Centre for Imaging Technology Commercialization (CIMTEC) As we age, the...

Canada's Innovation Leaders, November 7, 2014 Since 1998, the Government of Canada has invested more than $1billion in medical imaging R...

BIOTECanada article about CIMTEC customer KalGene Pharmaceuticals

The National Research Council and KalGene Pharmaceuticals recently announced an agreement to co-develop a new treatment against aggressive...

CIMTEC Chief Scientific Officer and Centre Director, Dr. Aaron Fenster, meeting with customers, 3D NerveVision

London, Ontario, September 10, 2014 – “Clinical testing has been one of the biggest barriers to developing new imaging technology for...

Sheep's kidney showing saline injection site imaged by OxEMA system

Earlier tumour diagnosis with advanced ultrasound technology from Oxford University TORONTO –Isis Innovation, the technology transfer arm...

NRC and KalGene Pharmaceuticals announce an agreement to co-develop a new treatment against aggressive brain cancers

Ottawa, Ontario, July 21, 2014 - The National Research Council of Canada (NRC) and KalGene Pharmaceuticals are proud to announce an...

Biotechnology Focus, CIMTEC launches spin-off company Focal Healthcare, Inc.

Biotechnology Focus, July 11, 2014 Focal Healthcare (Focal) was founded as a spin-off company out of the Centre for Imaging Technology...

KalGene Pharmaceuticals partners with CIMTEC

London, Ontario, June 12, 2014 – KalGene Pharmaceuticals, Inc. (KalGene) is expediting development of a prognostic marker and companion...

Pages